Home
Company
About us
Our Network
Our Team
Our Governance
Contact
Expertise
Personalize My Treatment (PMT)
Clinical Operations
Translational Operations
News
News
Publications
Newsletter
Français
Home
Company
About us
Our Network
Our Team
Our Governance
Contact
Expertise
Personalize My Treatment (PMT)
Clinical Operations
Translational Operations
News
News
Publications
Newsletter
Français
Day
July 9, 2019
09
Jul
Exactis publication highlights novel aberrations associated with clinical outcomes in ALK+ NSCLC patients on targeted therapy
9 July 2019
admin
News
Read the full article here.
Read More
Recent Posts
Newsletter #11 – May 5, 2021
Exactis’ is pleased to announce their latest publication in Clinical and Translational Medicine entitled “Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer”.
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
The Next Steps for Precision Oncology in Canada
Sermonix Pharmaceuticals Partners With Exactis Innovation for ELAINE 1 Clinical Trial Sites in Canada
